Helena Laboratories Point of Care   Report issue

For profit Phase 4
Founded: Beaumont TX United States (1966)
Status: No NME R&D (1966)

Organization Overview

First Clinical Trial
2009
NCT00766896
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

acetylsalicylic acid (aspirin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Atherosclerosis (Phase 4)

Cardiovascular Diseases (Phase 4)

Cerebral Infarction (Phase 4)

Infarction (Phase 4)

Ischemia (Phase 4)

Stroke (Phase 4)

Thrombosis (Phase 4)

Vascular Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1